Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007–2015

Objective The aim of this study was to analyse the changes in new certifications for both sight impairment (SI) and severe sight impairment (SSI, blindness) in Wales due to diabetic retinopathy (DR)/maculopathy between 2007 and 2015. Research design and methods This is a retrospective analysis of annual data of new certifications for visual impairment and blindness (Certificate of Vision Impairment) for England and Wales derived from the national database provided by the Certifications Office, Moorfields Eye Hospital, over a period of 8 years from 2007. Results In Wales there were 339 less new certifications for both SI and severe SSI from any cause combined from 2007–2008 to 2014–2015. The number SI and SSI combined specifically due to DR was reduced by 22 in people with known diabetes. This was a reduction in new certifications over the observation period from 82.4 to 46.9 per 100 000 (−43.1%) with a fall in SSI from 31.3 to 15.8 per 100 000 (−49.4%), respectively. During this observation period however, there was a parallel increase in 52 229 (39.8%) persons with diabetes in Wales. Conclusions While acknowledging the limitations of the certification process and the increasing numbers of persons with diabetes, the incidence of SI and SSI per 100 000 population of persons with diabetes in Wales has almost halved over an 8-year period up to 2015. This may reflect the earlier diagnosis of DR and sight-threatening DR since the introduction of screening and/or improved diabetes management with timely onward referral and newer treatments.

[1]  C. Bunce,et al.  How many people in England and Wales are registered partially sighted or blind because of age-related macular degeneration? , 2014, Eye.

[2]  J Clowes,et al.  Preservation of sight in diabetes: developing a national risk reduction programme , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[3]  R. Barry,et al.  Unregistered visual impairment: is registration a failing system? , 2005, British Journal of Ophthalmology.

[4]  M. J. MacDonald,et al.  Incidence of blindness due to diabetic eye disease in Fife 1990–9 , 2001, The British journal of ophthalmology.

[5]  Gretchen A. Stevens,et al.  Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. , 2013, Ophthalmology.

[6]  Gerald Liew,et al.  A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010 , 2014, BMJ Open.

[7]  Epidemiology of blindness attributable to diabetes in Scotland: change over 20 years in a defined population , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[8]  B. Klein,et al.  Assessing Progress in Retinopathy Outcomes in Type 1 Diabetes , 2013, Diabetes Care.

[9]  R. Klein,et al.  Rates of Progression in Diabetic Retinopathy During Different Time Periods , 2009, Diabetes Care.

[10]  C. Bunce,et al.  Causes of blind certifications in England and Wales: April 1999–March 2000 , 2008, Eye.

[11]  P. Hogan,et al.  Economic Costs of Diabetes in the U , 2013 .

[12]  D. Flanagan,et al.  Registration of visual impairment due to diabetic retinopathy in a subpopulation of Cambridgeshire , 2008, Clinical ophthalmology.

[13]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[14]  The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular Edema. , 2016, Ophthalmic surgery, lasers & imaging retina.

[15]  Ronald Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. , 2008, Ophthalmology.

[16]  A. Sorsby Blindness in England 1951-1954. , 1956 .

[17]  Richard Wormald,et al.  Leading causes of certification for blindness and partial sight in England & Wales , 2006, BMC public health.

[18]  N. Bressler,et al.  Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. , 2016, Ophthalmology.

[19]  A. Sorsby The Causes of Blindness in England 1948-1950. , 1953 .

[20]  C. Basch,et al.  Incentives and barriers to retinopathy screening among African-Americans with diabetes. , 1997, Journal of diabetes and its complications.

[21]  J. Gussekloo,et al.  Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance. , 2012, Diabetes research and clinical practice.

[22]  S. Sivaprasad,et al.  Socio‐economic and ethnic inequalities in diabetes retinal screening , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[23]  M. Maia,et al.  INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Results From the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up , 2016, Retina.

[24]  C. Bunce,et al.  BD8 certification of visually impaired people , 1998, The British journal of ophthalmology.

[25]  Certification for vision impairment: researching perceptions, processes and practicalities in health and social care professionals and patients , 2014, BMJ Open.

[26]  D. Owens,et al.  Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service , 2014, British Journal of Ophthalmology.

[27]  P. Boyle,et al.  Screening Uptake in a Well-Established Diabetic Retinopathy Screening Program , 2008, Diabetes Care.

[28]  J. Shaw,et al.  The cost of diabetes in adults in Australia. , 2013, Diabetes research and clinical practice.

[29]  M. C. Leske,et al.  Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. , 2001, Ophthalmology.

[30]  B. Klein,et al.  Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.

[31]  Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[32]  C. Bunce,et al.  BD8 certification of visually impaired people , 1998, The British journal of ophthalmology.

[33]  P. Kearney,et al.  Trends in blindness due to diabetic retinopathy among adults aged 18-69years over a decade in Ireland. , 2016, Diabetes research and clinical practice.

[34]  K. Boye,et al.  Health utility values associated with diabetic retinopathy , 2008, Diabetic medicine : a journal of the British Diabetic Association.